New mass spectrometry tool accurately identifies bacteria
Scientists identify bacterial species by analyzing their proteins using mass spectrometry, or MS. This technique first fragments proteins into smaller peptides using an enzyme called trypsin. These sequences can then be compared to references in databases. The largest MS-based studies on bacteria have focused on just a handful of species, so a team of researchers recently created a resource for mapping data onto a more diverse population of bacteria.

Miriam Abele, Armin Soleymaniniya and colleagues at the Technical University of Munich developed MS2Bac, a software system that enables bacterial identification from protein data. They published their resource in Molecular & Cellular Proteomics. MS2Bac maps tryptic peptides onto reference bacterial species or strains, achieving almost perfect accuracy for species identification. To develop this tool, the team first performed MS on the proteins from over 300 bacterial species to create a reference database. They also compared their identification method with other approaches, such as Fourier transform infrared spectroscopy, and found that MS2Bac was the most accurate.
MS2Bac can also identify specific proteins, antibiotic resistance markers. It covers many hypothetical proteins, which are not well understood, providing a basis for further functional studies. This is the first study to incorporate single-cell organisms into the ProteomicsDB database, a proteomics resource for multiomics analyses. This tool will greatly help researchers and clinicians determine bacterial species from clinically and environmentally relevant samples.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.